Status:
COMPLETED
Inflammation, Immune Activation and Portal Hypertension in Alcoholic Hepatitis
Lead Sponsor:
University of Aarhus
Conditions:
Alcoholic Hepatitis
Eligibility:
All Genders
18-69 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the role of endotoxins and the endotoxin mediated immune activation pathway in patients with alcoholic hepatitis. Also, to determine the effect of Liver ass...
Eligibility Criteria
Inclusion
- Patients with alcoholic hepatitis based on the following criteria
- Alcohol intake for 6 consecutive months above 40g /day, at admission or 3 months earlier.
- Serum bilirubin level above 80 mmol/l
- exclusion of other types of liver disease.
- Liver biopsy when diagnosis is unclear.
Exclusion
- Heart failure
- Pregnancy
- non fluent danish speakers
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00992888
Start Date
August 1 2009
End Date
September 1 2011
Last Update
September 15 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medicine V, Aarhus University Hospital
Aarhus, Denmark, 8000